Table 2.
Biomarkers of oxidative stress (Baseline to one month) | Platelet glycoproteins (baseline to one month) | |||
---|---|---|---|---|
GPIbα Surface | GPIbα Plasma | GPVI Surface | GPVI Plasma | |
Platelet ROS | ||||
Spearman’s ρ | −0.24 | 0.35 | −0.30 | 0.28 |
95% confidence intervals (CI) | −0.41 to −0.06 | 0.18 to 0.50 | −0.48 to −0.09 | 0.11 to 0.44 |
p-value | 0.01* | <0.0001* | 0.004* | 0.002* |
| ||||
Neutrophil ROS | ||||
Spearman’s ρ | −0.54 | 0.32 | −0.20 | 0.44 |
95% confidence intervals (CI) | −0.67 to −0.37 | 0.10 to 0.50 | −0.47 to 0.10 | 0.24 to 0.60 |
p-value | < 0.0001* | 0.004* | 0.17 | < 0.0001* |
| ||||
Lymphocyte ROS | ||||
Spearman’s ρ | −0.32 | 0.33 | −0.09 | 0.26 |
95% confidence intervals (CI) | −0.50 to −0.12 | 0.11 to 0.51 | −0.37 to 0.22 | 0.05 to 0.46 |
p-value | 0.002* | 0.003* | 0.57 | 0.02* |
| ||||
Monocyte ROS | ||||
Spearman’s ρ | −0.38 | 0.39 | −0.23 | 0.36 |
95% confidence intervals (CI) | −0.54 to −0.18 | 0.19 to 0.56 | −0.49 to 0.07 | 0.15 to 0.53 |
p-value | 0.0002* | 0.0002* | 0.12 | 0.001* |
| ||||
SOD | ||||
Spearman’s ρ | 0.54 | −0.51 | 0.59 | −0.57 |
95% confidence intervals (CI) | 0.40 to 0.66 | −0.64 to −0.36 | 0.42 to 0.72 | −0.69 to −0.43 |
p-value | < 0.0001* | < 0.0001* | < 0.0001* | < 0.0001* |
| ||||
TAC | ||||
Spearman’s ρ | 0.53 | −0.53 | 0.64 | −0.59 |
95% confidence intervals (CI) | 0.39 to 0.65 | −0.65 to −0.39 | 0.49 to 0.75 | −0.70 to −0.46 |
p-value | < 0.0001* | < 0.0001* | < 0.0001* | < 0.0001* |
| ||||
oxLDL | ||||
Spearman’s ρ | −0.57 | 0.60 | −0.63 | 0.60 |
95% confidence intervals (CI) | −0.68 to −0.44 | 0.47 to 0.71 | −0.75 to −0.48 | 0.48 to 0.71 |
p-value | < 0.0001* | < 0.0001* | < 0.0001* | < 0.0001* |
Note: Result was expressed as ρ (rho) value.
statistically significant in spearman’s rank correlation test.